轉移膜市場 - 全球產業規模、佔有率、趨勢、機會及預測（按產品、轉移方法、應用、最終用戶、地區和競爭格局分類），2021-2031年

全球傳熱膜市場預計將從 2025 年的 4.7215 億美元成長到 2031 年的 6.7393 億美元，複合年成長率為 6.11%。

這些轉移膜是特製的微孔薄膜，通常由聚二氟亞乙烯(PVDF)、硝化纖維素或尼龍等材料製成。它們用於固定核酸和蛋白質，例如在西方印漬術)等技術中，以便進行後續檢測。市場成長的主要驅動力是慢性病發病率的上升和生物製藥領域資金的增加，這推動了對各種蛋白質分析和診斷測試的需求。根據歐洲製藥工業協會聯合會 (EFPIA) 的報告，預計到 2024 年，歐洲製藥業將在研發方面投資約 550 億歐元，這凸顯了大量資金的流入，從而滿足了對這些關鍵實驗室耗材的高需求。

然而，由於替代檢測技術的興起，市場面臨著巨大的挑戰。數位分析平台和自動化印跡系統的日益普及，為大幅減少傳統物理膜的使用提供了可能。這種向自動化和數位化的轉變可能會擾亂標準轉印媒體的持續銷售量，從而對該細分市場的持續成長構成潛在障礙。

市場促進因素

全球感染疾病和慢性病負擔日益加重，是推動全球轉印膜市場發展的主要動力。隨著癌症等疾病的日益普遍，對可靠的蛋白質分析技術（例如蛋白質印跡法）和用於檢測生物標記的診斷工具的需求也與日俱增。需要進行分析的診斷數量之多，更凸顯了這種迫切性。例如，美國癌症協會於2025年1月發布的《2025年癌症事實與數據》報告預測，光是當年美國就將新增2,041,910例癌症病例。因此，這些疾病發生率的不斷上升，直接要求為用於治療監測和疾病檢測等關鍵流程的轉印膜建立一條穩健的供應鏈。

同時，生物製藥研發投入的不斷增加，為藥物發現所需的大規模實驗室運作提供了資金，從而推動了市場成長。製藥公司正投入創紀錄的資金用於新型生物製藥的研發，而使用微孔膜的蛋白質序列測定工作流程是這個過程的關鍵。例如，默克公司於2025年2月發布的「2024年第四季及全年財務業績」顯示，該公司全年非GAAP研發支出達到179億美元。這項企業投資，加上公共部門資金的進一步支持，鞏固了實驗室耗材生態系統。 2024年，美國衛生與公眾服務部報告稱，美國國立衛生研究院（NIH）的總預算支出達到473億美元。這些資金投入確保了學術界和商業研究機構對高品質轉染培養基的持續需求。

市場挑戰

由於替代檢測技術的出現和自動化印跡系統的日益普及，全球轉印膜市場面臨巨大的成長障礙。先進的數位平台通常採用液相法和毛細管電泳技術，往往可以消除或顯著減少對聚二氟亞乙烯和硝化纖維素等傳統微孔膜的需求。隨著越來越多的實驗室將重現性和效率放在首位，手動Western印跡技術的衰落直接導致標準轉印膜的重複銷售量下降，從而限制了膜生產商的商機。

這種轉變體現在產業對自動化實驗室解決方案的參與度不斷提高，這些解決方案與傳統耗材直接競爭。據實驗室自動化與篩檢協會 (SLAS) 稱，2024 年國際會議暨展覽將吸引創紀錄的 7500 名與會者和 400 家參展。如此大規模的參與證實了產業正加速向自動化技術轉型，這些技術能夠最佳化試劑使用並最大限度地減少物理廢棄物，從而逐步降低現代蛋白質分析工作流程中對傳統轉印膜的需求。

市場趨勢

自動化和單細胞西方印漬術平台的興起，正從根本上改變市場格局，其高通量能力和可重複性遠勝於傳統的手動方法。實驗室正日益採用單細胞解析度工具和數位成像系統，以提高數據準確性並簡化複雜的蛋白質分析流程。各大廠商正積極支持這項技術轉型，推出滿足新一代印跡解決方案需求的整合系統。例如，Bio-Rad Laboratories, Inc. 在 2024 年年度報告（2025 年 3 月發布）中宣布，將於 2024 年推出兩款全新的生命科學研究平台：ChemiDoc Go 成像系統和 ddSEQ 單細胞試劑盒。這些平台旨在滿足不斷變化的研究需求，並提高實驗效率。

同時，隨著產業適應全球永續性要求，向無溶劑、環保膜製造的轉型正在加速。生物技術和製藥公司優先考慮低碳供應鏈，這促使耗材供應商創新研發無溶劑生產流程，並減少與轉移介質相關的塑膠廢棄物。這一趨勢體現在整個產業設定雄心勃勃的氣候目標上，這些目標直接影響著籌資策略。根據My Green Lab於2024年11月發布的《2024年生物技術和製藥行業碳影響報告》，該行業31%的公司已設定與1.5°C排放目標相一致的中期範圍1和範圍2減排目標，從而對支持這些環境目標的永續實驗室材料產生了強勁的需求。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球傳輸膜市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 副產物（聚偏氟乙烯、硝化纖維素、尼龍）
  • 按轉印法（濕式或槽式轉印、半乾式電轉印、乾式電轉印、其他）
  • 透過應用（蛋白質印跡法、蛋白質印跡法、蛋白質印跡法等）
  • 依最終用戶（生物製藥/製藥公司、學術/研究機構、診斷檢查室、其他）分類
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章 北美傳輸膜市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

7. 歐洲傳輸膜市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

8. 亞太地區傳輸膜市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

9. 中東和非洲傳輸膜市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲傳輸膜市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球傳質膜市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Thermo Fisher Scientific, Inc.
• Danaher Corporation
• Merck KGaA
• PerkinElmer, Inc.
• Abcam Plc.
• Santa Cruz Biotechnology, Inc.
• ATTO Corporation
• Azure Bio systems Inc.
• Advansta Inc.
• GVS SpA

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Transfer Membrane Market is projected to expand from USD 472.15 Million in 2025 to USD 673.93 Million by 2031, registering a CAGR of 6.11%. These transfer membranes are specialized microporous films, usually made from materials like polyvinylidene difluoride (PVDF), nitrocellulose, or nylon, and are engineered to immobilize nucleic acids and proteins for subsequent detection in methods such as Western blotting. Market growth is largely propelled by the increasing incidence of chronic diseases alongside rising biopharmaceutical funding, which drives the need for extensive protein analysis and diagnostic testing. As reported by the European Federation of Pharmaceutical Industries and Associations, the pharmaceutical sector invested approximately €55 billion in research and development across Europe in 2024, highlighting the significant capital flow that supports the high demand for these critical laboratory consumables.

Conversely, the market faces a significant obstacle stemming from the rise of alternative detection technologies. The growing uptake of digital analysis platforms and automated blotting systems offers a method to considerably lower the usage of traditional physical membranes. This shift toward automation and digitization threatens to impede the volume of recurring sales for standard transfer media, presenting a potential barrier to sustained market growth in this segment.

Market Driver

The escalating global burden of infectious and chronic diseases acts as a major driver for the Global Transfer Membrane Market. As conditions such as cancer become more prevalent, there is a heightened demand for dependable protein analysis techniques, such as Western blotting, and diagnostic tools to detect biomarkers. This urgency is underscored by the sheer volume of diagnoses requiring analysis; for instance, the American Cancer Society's 'Cancer Facts & Figures 2025' report from January 2025 projects that 2,041,910 new cancer cases will be diagnosed in the United States alone during that year. Consequently, the growing incidence of these diseases creates a direct necessity for resilient supply chains of transfer membranes utilized in the essential processes of therapeutic monitoring and disease detection.

Concurrently, increased investment in biopharmaceutical research and development is fueling market growth by financing the extensive laboratory operations needed for drug discovery. Pharmaceutical companies are directing record amounts of capital toward developing novel biologics, a process that relies heavily on protein sequencing workflows involving these microporous films. To illustrate, Merck's 'Fourth-Quarter and Full-Year 2024 Financial Results' from February 2025 revealed that the company's non-GAAP research and development expenses hit $17.9 billion for the full year. This corporate investment is bolstered by public sector funding, which further secures the ecosystem for laboratory consumables; in 2024, the U.S. Department of Health and Human Services reported that the National Institutes of Health (NIH) received a total enacted program level of $47.3 billion. Collectively, these financial commitments guarantee a continuous demand for high-grade transfer media across both academic and commercial research environments.

Market Challenge

The Global Transfer Membrane Market encounters a substantial barrier to growth arising from the advent of alternative detection technologies and the rising implementation of automated blotting systems. Advanced digital platforms, which frequently employ fluid-based methods or capillary electrophoresis, often eliminate or significantly decrease the need for traditional microporous films like polyvinylidene difluoride and nitrocellulose. As laboratories increasingly value reproducibility and efficiency, the transition away from manual Western blotting techniques leads to a direct reduction in recurring sales volumes for standard transfer media, thereby restricting revenue opportunities for membrane manufacturers.

This shift is highlighted by growing industrial involvement with automated laboratory solutions that compete directly with traditional consumables. According to the Society for Laboratory Automation and Screening, its 2024 International Conference and Exhibition drew a record 7,500 attendees and 400 exhibitors. Such significant participation underscores the accelerating industry trend toward automation technologies that optimize reagent use and minimize physical waste, a movement that is progressively diminishing the demand for conventional transfer membranes within modern protein analysis workflows.

Market Trends

The movement toward automated and single-cell Western blotting platforms is fundamentally transforming the market by emphasizing high-throughput capabilities and reproducibility over conventional manual methods. Laboratories are increasingly adopting single-cell resolution tools and digital imaging systems to improve data accuracy and simplify complex protein analysis workflows. Leading manufacturers are actively supporting this technological shift by releasing integrated systems to satisfy the need for next-generation blotting solutions. For example, Bio-Rad Laboratories noted in its '2024 Annual Report' from March 2025 that it launched two new Life Science research platforms in 2024-the ChemiDoc Go Imaging System and the ddSEQ Single-Cell Kit-specifically engineered to meet these changing research requirements and enhance experimental efficiency.

Simultaneously, the transition toward solvent-free and eco-friendly membrane manufacturing is accelerating as the industry conforms to global sustainability mandates. Biotechnology and pharmaceutical organizations are prioritizing low-carbon supply chains, which compels consumable suppliers to innovate solvent-free production techniques and decrease plastic waste related to transfer media. This push is quantified by the ambitious climate targets being set throughout the sector, which directly impact procurement strategies. According to the '2024 Carbon Impact of Biotech & Pharma Report' by My Green Lab in November 2024, 31% of companies in the industry have established medium-term Scope 1 and 2 targets consistent with a 1.5°C pathway, generating strong demand for sustainable laboratory materials that support these environmental goals.

Key Market Players

• Thermo Fisher Scientific, Inc.
• Danaher Corporation
• Merck KGaA
• PerkinElmer, Inc.
• Abcam Plc.
• Santa Cruz Biotechnology, Inc.
• ATTO Corporation
• Azure Bio systems Inc.
• Advansta Inc.
• GVS S.p.A.

Report Scope

In this report, the Global Transfer Membrane Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Transfer Membrane Market, By Product

• PVDF
• Nitrocellulose
• Nylon

Transfer Membrane Market, By Transfer Method

• Wet or Tank Transfer
• Semi-dry Electro Blotting (Semi-dry Transfer)
• Dry Electro Blotting (Dry Transfer)
• Others

Transfer Membrane Market, By Application

• Western Blotting
• Southern Blotting
• Northern Blotting
• Others

Transfer Membrane Market, By End User

• Biopharmaceutical & Pharmaceutical Companies
• Academic & Research Institutes
• Diagnostic Labs
• others

Transfer Membrane Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Transfer Membrane Market.

Available Customizations:

Global Transfer Membrane Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Transfer Membrane Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (PVDF, Nitrocellulose, Nylon)
  • 5.2.2. By Transfer Method (Wet or Tank Transfer, Semi-dry Electro Blotting (Semi-dry Transfer), Dry Electro Blotting (Dry Transfer), Others)
  • 5.2.3. By Application (Western Blotting, Southern Blotting, Northern Blotting, Others)
  • 5.2.4. By End User (Biopharmaceutical & Pharmaceutical Companies, Academic & Research Institutes, Diagnostic Labs, others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Transfer Membrane Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Transfer Method
  • 6.2.3. By Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Transfer Membrane Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Transfer Method
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Transfer Membrane Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Transfer Method
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Transfer Membrane Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Transfer Method
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe Transfer Membrane Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Transfer Method
  • 7.2.3. By Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Transfer Membrane Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Transfer Method
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. France Transfer Membrane Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Transfer Method
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Transfer Membrane Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Transfer Method
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Transfer Membrane Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Transfer Method
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Transfer Membrane Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Transfer Method
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia Pacific Transfer Membrane Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Transfer Method
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Transfer Membrane Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Transfer Method
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Transfer Membrane Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Transfer Method
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Transfer Membrane Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Transfer Method
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Transfer Membrane Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Transfer Method
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Transfer Membrane Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Transfer Method
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. Middle East & Africa Transfer Membrane Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Transfer Method
  • 9.2.3. By Application
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Transfer Membrane Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Transfer Method
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE Transfer Membrane Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Transfer Method
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa Transfer Membrane Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Transfer Method
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. South America Transfer Membrane Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Transfer Method
  • 10.2.3. By Application
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Transfer Membrane Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Transfer Method
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia Transfer Membrane Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Transfer Method
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina Transfer Membrane Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Transfer Method
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Transfer Membrane Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Thermo Fisher Scientific, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Danaher Corporation
• 15.3. Merck KGaA
• 15.4. PerkinElmer, Inc.
• 15.5. Abcam Plc.
• 15.6. Santa Cruz Biotechnology, Inc.
• 15.7. ATTO Corporation
• 15.8. Azure Bio systems Inc.
• 15.9. Advansta Inc.
• 15.10. GVS S.p.A.

16. Strategic Recommendations

17. About Us & Disclaimer